Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS)
Publication
, Journal Article
Diener, HC; Easton, JD; Granger, CB; Kreuzer, J; Duffy, C; Cotton, D; Brueckmann, M; Sacco, RL
Published in: INTERNATIONAL JOURNAL OF STROKE
October 1, 2014
Duke Scholars
Published In
INTERNATIONAL JOURNAL OF STROKE
EISSN
1747-4949
ISSN
1747-4930
Publication Date
October 1, 2014
Volume
9
Start / End Page
216 / 216
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Neurology & Neurosurgery
- 4201 Allied health and rehabilitation science
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Diener, H. C., Easton, J. D., Granger, C. B., Kreuzer, J., Duffy, C., Cotton, D., … Sacco, R. L. (2014). Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). INTERNATIONAL JOURNAL OF STROKE, 9, 216–216.
Diener, H. C., J. D. Easton, C. B. Granger, J. Kreuzer, C. Duffy, D. Cotton, M. Brueckmann, and R. L. Sacco. “Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS).” INTERNATIONAL JOURNAL OF STROKE 9 (October 1, 2014): 216–216.
Diener HC, Easton JD, Granger CB, Kreuzer J, Duffy C, Cotton D, et al. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). INTERNATIONAL JOURNAL OF STROKE. 2014 Oct 1;9:216–216.
Diener, H. C., et al. “Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS).” INTERNATIONAL JOURNAL OF STROKE, vol. 9, WILEY-BLACKWELL, Oct. 2014, pp. 216–216.
Diener HC, Easton JD, Granger CB, Kreuzer J, Duffy C, Cotton D, Brueckmann M, Sacco RL. Rationale, objectives and design of a secondary stroke prevention study of dabigatran etexilate versus acetylsalicylic acid in patients with embolic stroke of undetermined source (RE-SPECT-ESUS). INTERNATIONAL JOURNAL OF STROKE. WILEY-BLACKWELL; 2014 Oct 1;9:216–216.
Published In
INTERNATIONAL JOURNAL OF STROKE
EISSN
1747-4949
ISSN
1747-4930
Publication Date
October 1, 2014
Volume
9
Start / End Page
216 / 216
Publisher
WILEY-BLACKWELL
Related Subject Headings
- Neurology & Neurosurgery
- 4201 Allied health and rehabilitation science
- 3209 Neurosciences
- 3202 Clinical sciences
- 1109 Neurosciences
- 1103 Clinical Sciences